Mostafa Belghasem, MBChB, PhD

Biography

Associate Professor

Biomedical Science

Before joining Kaiser Permanente Bernard J. Tyson School of Medicine, Dr. Mostafa Belghasem served as assistant professor of pathology and laboratory medicine; associate director of the Master of Science in Pathology; and director of the second-year pathology curriculum at Boston University School of Medicine. Dr. Belghasem has demonstrated a lifelong commitment to teaching and mentoring graduate medical students, residents, and research fellows. He has received several awards for excellence in teaching and advancing the field of experimental pathology, and has developed course content on histopathology, pathophysiology, and medical immunology.

Education and Training

Degrees: MD, Tripoli University
MA, Boston University
PhD, Boston University

Residency: Intern, Resident, Tripoli Medical Center

Professional Positions

Lecturer: Metropolitan College, Boston University; 2015-2018

Instructor of Pathology and Laboratory Medicine: Boston University School of Medicine; 2017-2019

Assistant Professor of Pathology and Laboratory Medicine: Boston University School of Medicine; 2019

Honors and Awards

O’Brien Workshop on Applied Microscopy in Kidney Research Award: Indianapolis University; 2013

Howard Hughes Medical Institute Scholarship Award: The Jackson Laboratory, 13th Annual Workshop on the Pathology of Mouse Models for Human Disease; 2014

ASN 2014 Kidney STARS Award: American Society of Nephrology (ASN) Kidney Week 2014; 2014

Teaching as Research Fellowship Award: Boston University; 2014

The Excellence Award for Outstanding Contributions: Department of Pathology, Boston University; 2016

Scholarly Activities

Peer-reviewed research manuscripts

Belghasem ME, A'Amar O, Roth D, Walker J, Arinze N, Richards S, Francis J, Salant D, Chitalia V, Bigio IJ. Towards minimally-invasive, quantitative assessment of chronic kidney disease using optical spectroscopy. Scientific Reports. May 9 2019;9(1):7168.
Belghasem M. Roth D. Richards S, Napoleon M, Walker J, Yin W, Arinze N, Lyle C, Spencer C, Francis J M, Thompson C, Andry C, Whelan SA, Lee N, Ravid K, Chitalia, V C. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood. Dec 26 2019;134(26):2399-2413.
Addo-Tabiri NO, Chudasama R, Vasudeva R, Leiva O, Garcia B, Ravid JD, Bunze T, Rosen L, Belghasem M, Francis J, Brophy M, Johnson B, Ferguson R, Weinberg J, Chitalia VC. Black Patients Experience Highest Rates of Cancer-Associated Venous Thromboembolism. American Journal of Clinical Oncology. Dec 4 2019.
Walker J, Richards S, Belghasem ME, Arinze N, Yoo SB, Tashjian JY, Whelan SA, Lee N, Kolachalama JF, Ravid K, Sherr D, Chitalia VC. Temporal and Tissue-Specific Activation of Aryl Hydrocarbon Receptor in Discrete Mouse Models of Kidney Disease. Kidney International. Oct 30 2019.
Lyle C, Richards S, Yasuda K, Arinze N, Walker J, Belghasem M, Vellard I, Amraei R, Francis Ja, Phtak U, Rifkin I, Rahimi N, Ravid J, Zavaro E, Yin W, Napoleon M, Chitalia V. c-Cbl Targets PD-1 in Immune Cells for Proteasomal Degradation and Modulates Colorectal Tumor Growth. Scientific Reports. Dec 27 2019;9(1):20257
Lyle CL, Belghasem M, Chitalia VC. c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. Cells. May 23 2019;8(5).
Shashar M, Belghasem M, Matsuura S, Alousi F, Rijal K, Kolachalama VB, Balcells M, Nagasawa K, Henderson JM, Gautam Am, Francis J, Kolandaivelu K, Sherr DH, Ravid K, Chitalia VC. Targeting STUB1-Tissue Factor Axis Normalizes Hyperthrombotic Uremic Phenotype Without Increasing Bleeding Risk. Science Translational Medicine. Nov 22 2017;9(417).